PARTNERING WITH RADISENS
Partnering with Radisens
Radisens Diagnostics has a business to business commercial approach with the aim to develop strategic partnerships. These include technology licensing, strategic investment, manufacturing and distribution relationships with collaborators to develop and grow the iron deficiency screening market at the point of care. In addition, the Gemini™ platform is expandable for the measurement of analytes other than those in development by Radisens.
Radisens Diagnostics is leading a €6 million grant-aided FerrTest consortium, including Trinity College Dublin, Irish Manufacturing Research and PolyPico Technologies. This will complete product & process development and scale-up ahead of pre-clinical trials. Radisens seeks partner(s) to commence this project and support commercialisation of the Gemini™ platform.